In Q1'26, CPNG's total operating expenses reached $2.54B USD, driven entirely by SG&A expenses at $2.54B USD, as R&D expenses remained at no data across all periods. This marks a slight uptick of 0.1% from Q4'25's $2.54B USD, reflecting ongoing stability in administrative and general costs. From Q2'23 to Q1'26, SG&A expenses exhibited a clear upward trend, surging from $1.38B USD to $2.54B USD—a compound annual growth rate of approximately 20%—with notable acceleration in early 2024 before stabilizing around $2.5B USD in later quarters. R&D expenses showed no data throughout, indicating a potential focus on operational efficiency rather than research investment; the stacked bar chart underscores SG&A as the dominant component, comprising 100% of operating expenses and highlighting cost management as a key area for financial analysts to monitor amid revenue growth.